Inotiv, Inc.
US ˙ NasdaqCM ˙ US45783Q1004

SecurityNOTV / Inotiv, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership331,810 shares
Latest Disclosed Value $ 90,417
BlackRock, Inc. reports 2.23% increase in ownership of NOTV / Inotiv, Inc.

On May 13, 2026 - BlackRock, Inc. filed a 13F-HR form disclosing ownership of 331,810 shares of Inotiv, Inc. (US:NOTV) valued at $90,418 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 324,570 shares of Inotiv, Inc.. This represents a change in shares of 2.23% during the quarter. The current value of the position is $28,735 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F INOTIV COM 45783Q100 331,810 7,240 2.23 90 -50.55 0.0000
2026-02-12 2025-12-31 13F INOTIV COM 45783Q100 324,570 14,346 4.62 182 -59.47 0.0000
2025-11-12 2025-09-30 13F INOTIV COM 45783Q100 310,224 97,438 45.79 450 16.02 0.0000
2025-08-12 2025-06-30 13F INOTIV COM 45783Q100 212,786 0 0.00 387 -17.66 0.0000
2025-05-02 2025-03-31 13F INOTIV COM 45783Q100 212,786 0 0.00 470 -46.59 0.0000
2025-02-07 2024-12-31 13F INOTIV COM 45783Q100 212,786 0 0.00 881 143.77 0.0000
2024-11-13 2024-09-30 13F INOTIV COM 45783Q100 212,786 0 0.00 362 2.27 0.0000
2024-08-13 2024-06-30 13F INOTIV COM 45783Q100 212,786 0 0.00 353 -84.83 0.0000
2024-05-10 2024-03-31 13F INOTIV COM 45783Q100 212,786 -3,351 -1.55 2,328 193.44 0.0001
2024-02-13 2023-12-31 13F INOTIV COM 45783Q100 216,137 0 0.00 793 19.25 0.0000
2023-11-13 2023-09-30 13F INOTIV COM 45783Q100 216,137 -14,608 -6.33 666 -39.55 0.0000
2023-08-11 2023-06-30 13F INOTIV COM 45783Q100 230,745 -991,257 -81.12 1,101 -79.21 0.0000
2023-05-12 2023-03-31 13F INOTIV COM 45783Q100 1,222,002 129,084 11.81 5,291 -2.00 0.0002
2023-02-13 2022-12-31 13F INOTIV COM 45783Q100 1,092,918 59,252 5.73 5,399 -69.00 0.0002
2022-11-14 2022-09-30 13F INOTIV COM 45783Q100 1,033,666 -23,326 -2.21 17,417 71.65 0.0006
2022-08-12 2022-06-30 13F INOTIV COM 45783Q100 1,056,992 73,191 7.44 10,147 -60.60 0.0003
2022-05-12 2022-03-31 13F INOTIV COM 45783Q100 983,801 57,382 6.19 25,756 -33.92 0.0007
2022-02-10 2021-12-31 13F INOTIV COM 45783Q100 926,419 262,728 39.59 38,975 100.84 0.0010
2021-11-09 2021-09-30 13F INOTIV COM 45783Q100 663,691 27,944 4.40 19,406 14.40 0.0005
2021-08-11 2021-06-30 13F INOTIV COM 45783Q100 635,747 602,245 1,797.64 16,963 2,431.79 0.0005
2021-05-07 2021-03-31 13F INOTIV COM 45783Q100 33,502 2,801 9.12 670 77.72 0.0000
2021-02-05 2020-12-31 13F BIOANALYTICAL SYS COM 09058M103 30,701 -21 -0.07 377 158.22 0.0000
2020-11-06 2020-09-30 13F BIOANALYTICAL SYS COM 09058M103 30,722 3,068 11.09 146 5.04 0.0000
2020-08-14 2020-06-30 13F BIOANALYTICAL SYS COM 09058M103 27,654 20,830 305.25 139 531.82 0.0000
2020-05-01 2020-03-31 13F BIOANALYTICAL SYS COM 09058M103 6,824 570 9.11 22 -29.03 0.0000
2020-02-13 2019-12-31 13F BIOANALYTICAL SYS COM 09058M103 6,254 129 2.11 31 40.91 0.0000
2019-11-08 2019-09-30 13F BIOANALYTICAL SYS COM 09058M103 6,125 413 7.23 22 100.00 0.0000
2019-08-22 2019-06-30 13F/A-1 BIOANALYTICAL SYS COM 09058M103 5,712 563 10.93 11 0.00 0.0000
2019-08-13 2019-06-30 13F BIOANALYTICAL SYS COM 09058M103 5,712 563 11
2019-05-09 2019-03-31 13F BIOANALYTICAL SYS COM 09058M103 5,149 465 9.93 11 83.33 0.0000
2019-02-08 2018-12-31 13F BIOANALYTICAL SYS COM 09058M103 4,684 577 14.05 6 -14.29 0.0000
2018-11-09 2018-09-30 13F BIOANALYTICAL SYS COM 09058M103 4,107 157 3.97 7 0.00 0.0000
2018-08-09 2018-06-30 13F BIOANALYTICAL SYS COM 09058M103 3,950 356 9.91 7 16.67 0.0000
2018-05-09 2018-03-31 13F BIOANALYTICAL SYS COM 09058M103 3,594 168 4.90 6 -25.00 0.0000
2018-02-09 2017-12-31 13F BIOANALYTICAL SYS COM 09058M103 3,426 236 7.40 8 33.33 0.0000
2017-11-14 2017-09-30 13F BIOANALYTICAL SYS COM 09058M103 3,190 399 14.30 6 20.00 0.0000
2017-08-10 2017-06-30 13F BIOANALYTICAL SYS COM 09058M103 2,791 508 22.25 5 66.67 0.0000
2017-05-12 2017-03-31 13F BIOANALYTICAL SYS COM 09058M103 2,283 2,283 3 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.